PolicyEconomic Times
Compulsory licensing of drugs only after exhausting other measures
Positive+33
GreyOak summary
The Department of Pharmaceuticals secretary stated that compulsory licensing for expensive medicines will be considered only after exhausting alternatives like price negotiations and bulk purchases. The government is currently examining trade margin rationalization for high-cost cancer drugs used in hospitals. Discussions are ongoing to improve access to patented drugs through various insurance and government schemes.
What it affects
- HealthcarePositive +33
Rolling sentiment Positive +37
